The legal position of the medical representative
The Measures for the Administration of Medical Representative Registration (2021) defines the medical representative's statutory role: a professional conveying drug information, communication and feedback — not a salesperson. This is a fundamental shift.
- Convey safety and efficacy information to healthcare professionals
- Collect and feed back clinical-use and adverse-reaction information
- Prohibited from undertaking drug sales tasks — the core prohibition
- Prohibited from counting doctors' prescriptions
- Prohibited from paying healthcare professionals any reward in exchange for prescriptions
The core target of the 2023 campaign: performance pay tied to prescription volume — companies calculating reps' bonuses by the prescriptions of the hospitals/doctors they cover — is treated as the institutionalised form of "kickback-driven selling". Many companies have been forced to reform their sales-incentive schemes. We recommend immediately reviewing current incentive plans to strip out any metric directly or indirectly linked to prescription volume.
The registration (filing) system
- Who files: the MAH files its medical representatives on the designated NMPA platform.
- Information: name, photo, MAH, promoted products and territories.
- Changes and de-registration: the MAH must update within 30 days of departure, territory or product changes.
- Doctors' verification right: healthcare professionals may verify a rep's registration and refuse unregistered or mismatched reps.
SOPs for academic-promotion activities
Academic promotion is the rep's core work, but the line between "academic promotion" and "disguised benefit transfer" is not always clear. We recommend standardised SOPs covering:
Academic visits
- Reasonable limits on frequency and duration (e.g. 2–4 times per doctor per month, ≤15 minutes each)
- Visits in public or designated academic areas, not disrupting clinical work
- No gifts, samples (except where law permits) or hospitality
- A record of each visit — who, topic and duration
Organising and sponsoring meetings
- A genuine academic agenda and qualified speakers
- Appropriate venues matching the academic nature — not luxury resorts or golf courses
- Reasonable, moderate travel and accommodation support for attendees
- Speaker fees at clear, fair-market rates, with a written agreement, actual delivery and tax withholding
- Working meals, not lavish banquets
Speaker fees — the highest-risk area
Speaker fees are the most common — and most easily breached — aspect of HCP interaction. Legitimate fees vs. disguised kickbacks:
- ✓ Legitimate: genuine expertise and qualification, academically valuable content, market-consistent amount, written agreement, actual delivery, tax withholding and book-recorded payment.
- ✗ Disguised kickback: speaker on paper only, grossly inflated fees, fees correlated with prescribing volume, or fees without tax withholding.
Responding to regulatory investigation
- Dawn-raid contingency planning and staff training
- Real-time legal advice during investigations (enforcement authority and company rights)
- Evidence collection and legal assessment
- Administrative-stage responses — hearings, statements and remediation commitments
- Criminal-defence strategy after formal filing